Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al.

Podobne zapisy

• Reply to ‘Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al.’
  od: Faconti, Luca, i wsp.
  Wydane: (2019)
• Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomized controlled VaSera trial
  od: Faconti, Luca, i wsp.
  Wydane: (2018)
• A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone
  od: Mills, Charlotte E., i wsp.
  Wydane: (2020)
• A study of the VaSera arterial stiffness device in US patients
  od: Maliha, George, i wsp.
  Wydane: (2017)
• P.55 Dietary Nitrate Prevents Progression of Carotid Subclinical Atherosclerosis Through BP-Independent Mechanisms in Patients with or at Risk of Type 2 Diabetes Mellitus: Results from the Double-Blind, Randomized-Controlled, Factorial Vasera Trial
  od: Franca Morselli, i wsp.
  Wydane: (2020-12-01)